Predictive Factors of Renal Damage during Sickle Cell Disease at the Hematology-Oncology Department of Donka University Hospital — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Predictive Factors of Renal Damage during Sickle Cell Disease at the Hematology-Oncology Department of Donka University Hospital
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Hematology-Oncology Department of Donka University Hospital, Conakry, Guinea
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Hematology-Oncology Department of Ignace Deen University Hospital, Conakry, Guinea
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
,
Medical Care Clinic, Freetown, Sierra-Leone
,
Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
1 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
2 Hematology-Oncology Department of Donka University Hospital, Conakry, Guinea
3 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
4 Hematology-Oncology Department of Ignace Deen University Hospital, Conakry, Guinea
5 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
6 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
7 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
8 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
9 Medical Care Clinic, Freetown, Sierra-Leone
10 Nephrology-Hemodialysis Department of Donka University Hospital, Conakry, Guinea
Introduction: Sickle cell disease, which is the most common hereditary hemoglobinopathy in the world, attacks all body systems, particularly the kidneys. The view of this study was to investigate the predictive factors of kidney damage during sickle cell disease. Materials and methods: It was a retrospective, descriptive and analytical study on files of sickle cell patients hospitalized in the Hematology-Oncology Department of Donka University Hospital during a period from January 1, 2016 to December 31, 2019. Records of sickle cell patients with one or more renal abnormalities were retained. Sickle cell patients without kidney damage were also selected for a comparative study. Only patients without sickle cell disease were excluded. Results: Seventy-five (75) medical records were collected during the study period. From these cases, thirteen (13) records with kidney disease were observed, a frequency of 17%. The mean age of patients was 24.2 years for extremes of 10 and 65 years. The sex ratio was 1.6 in favor of men. The SSFA 2 form was the most represented with 92%. 24-hour proteinuria was measured in 13 patients between whom 6 patients (46.2%) had a proteinuria level ≤ 1 g. Eight (8) patients (61.5%) were in stage 1 of chronic kidney disease. The most common type of renal involvement was tubulo-interstitial nephropathy with 8 patients (61.5%). Bivariate analysis showed that elevated serum creatinine (P < 0.001), elevated serum uremia (P < 0.001) and the SSFA 2 form of the sickness (P < 0.003) were the main factors linked with renal damage in sickle cell patients. Conclusio n: After the observation of an increased serum creatinine and urea, a predominance observation of the SSFA 2 form, it should be possible to target patients for whom screening for kidney damage should henceforth be systematic.
Chies, J.A.B. and Nardi, N.B. (2001) Sickle Cell Disease: A Chronic Inflammatory Condition. Medical Hypotheses , 57, 46-50. https://doi.org/10.1054/mehy.2000.1310
Ataga, K.I., Derebail, V.K. and Archer, D.R. (2014) The Glomerulopathy of Sickle Cell Disease. American Journal of Hematology , 89, 907-914. https://doi.org/10.1002/ajh.23762
Ndiaye, F.S.D., Fall, S., Niang, A., Diop, S. and Diouf, B. (2006) L’insuffisance rénale chronique chez les drépanocytaires SS à Dakar. Revue Internationale des Sciences Médicales , 8, 23-26.
Raynal, G., Bracq, A., Tillou, X., Limani, K. and Petit, J. (2007) Les complications rénales de la drépanocytose. Progrès en Urologie , 17, 794-795. https://doi.org/10.1016/s1166-7087(07)92294-0
Asnani, M., Serjeant, G., Royal‐Thomas, T. and Reid, M. (2016) Predictors of Renal Function Progression in Adults with Homozygous Sickle Cell Disease. British Jou r nal of Haematology , 173, 461-468. https://doi.org/10.1111/bjh.13967
Pondarré, C. (2008) Surveillance rénale au cours de la drépanocytose. Medecine Therapeutique Pediatrie , 11, 47-51.
Bouanani, N., El Bakkouri, J., Faez, S. and Benchemsi, N. (2013) L’atteinte rénale chez les patients drépanocytaires. Laboratoires d’Hématologie CHU Ibn Rochd Casablanca. Revues Scientifiques Marocaines , 8, 42-45.
Nke Ateba, G., Ngo Sack, F.F., Ateba, M.H.G. and Ngongang, J. (2017) Exploration de la fonction glomérulaire chez les drépanocytaires homozygotes à Yaoundé. Health Sciences and Disease , 18, 65-69. https://www.hsd-fmsb.org/index.php/hsd
Fongoro, S., Diallo, D., Diallo, D.A., Tchiango, K.A. and Maiga, M.K. (2009) Atteintes rénales associées au gène de la drépanocytose dans le service de Néphrologie et d’hémodialyse du CHU du Point G. Le Mali Médical, 53-56. https://www.bibliosante.ml/handle/123456789/3413
Ackoundou-N’Guessan, C., Guei, C.M., Lagou, D.A., Gbekedi, S., Tia, M.W., Coulibaly, P.A., et al . (2016) Insuffisance rénale chronique au cours de la drépanocytose: Une analyse rétrospective de 100 patients adultes drépanocytaires majeurs d’Afrique noire. Néphrologie & Thérapeutique , 12, 149-155. https://doi.org/10.1016/j.nephro.2015.08.004
Kanté, A.S., Diakité, F., Diakité, M., Traoré, M., Baldé, M.S., Bah, M., Kaba, D. and Kaba, M.L. (2019) Evaluation de la fonction rénale chez le sujet drépanocytaire dans le service d’Hématologie-Oncologie de l’Hôpital National De Donka. Afrique B i omédicale , 24, 58-61.
Action contre l’Ebola. Mission des Nations Unies pour l’action d’urgence contre l’Ebola (MINUAUCE), Guinée. https://ebolaresponse.un.org/fr/guinee
Organisation mondiale de la Santé (2021) Bulletins d’information sur les flambées épidémiques. https://www.who.int/fr/emergencies/disease-outbreak-news/item/2021-DON328
UNICEF Guinée (2023) La vaccination COVID-19 intégrée aux programmes de routine. https://www.unicef.org/guinea/recits/la-vaccination-covid-19-intégrée-aux-programmes-de-routine
Flambée de maladie à coronavirus 2019 (COVID-19). https://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019
Sundd, P., Gladwin, M.T. and Novelli, E.M. (2019) Pathophysiology of Sickle Cell Disease. Annual Review of Pathology : Mechanisms of Disease , 14, 263-292. https://doi.org/10.1146/annurev-pathmechdis-012418-012838
Pham, P.T., Pham, P.T., Wilkinson, A.H. and Lew, S.Q. (2000) Renal Abnormalities in Sickle Cell Disease. Kidney International , 57, 1-8. https://doi.org/10.1046/j.1523-1755.2000.00806.x
Wesson, D.E. (2002) The Initiation and Progression of Sickle Cell Nephropathy. Kidney International , 61, 2277-2286. https://doi.org/10.1046/j.1523-1755.2002.00363.x
Fall, S., Seck, M., Cissé, M.M., Ndiaye, F.S.D., Sarr, G.N., Diop, S., Niang, A., Diagne, I. and Diouf, B. (2010) Les atteintes rénales associées à la drépanocytose homozygote SS à Dakar. Dakar Medical , 55, 145-148.
Haute Autorité de Santé (2010) Syndromes drépanocytaires majeurs de l’adulte, protocole national de diagnostic et de soins pour une maladie rare: Protocole national de diagnostic et de soins pour une maladie rare. https://www.has-sante.fr/
Thiam, L., Dramé, A., Coly, I.Z., Diouf, F.N., Seck, N., Boiro, D., et al . (2017) Profils épidemiologiques, cliniques et hématologiques de la drépanocytose homozygote SS en phase inter critique chez l’enfant à Ziguinchor, Sénégal. Pan African Medical Journal , 28, Article 208. https://doi.org/10.11604/pamj.2017.28.208.14006
Haute Autorité de Santé (2010) Haute Autorité de la Santé. Syndrome drépanocytaire majeur de l’adulte. Protocole national de diagnostic et de soins pour une maladie rare. 87. https://www.has-sante.fr
Adekile, A.D., McKie, K.M., Adeodu, O.O., Sulzer, A.J., Liu, J.‐S., McKie, V.C., et al . (1993) Spleen in Sickle Cell Anemia: Comparative Studies of Nigerian and U.S. Patients. American Journal of Hematology , 42, 316-321. https://doi.org/10.1002/ajh.2830420313
Gianella, P. and Stucker, F. (2013) Prise en charge de l’anémie rénale en 2013. Revue Médicale Suisse , 9, 462-467. https://doi.org/10.53738/revmed.2013.9.375.0462
Mamady, D., Sayon, K.A., Alhassane, D., Moussa, B., Djongbe, C. and Aissata, T. (2019) Les Complications Osseuses au Cours de la Drepanocytose au Service d’Hematologie-Oncologie du CHU de Donka de Conakry. European Scientific Journal , 15, 252-258. https://doi.org/10.19044/esj.2019.v15n12p252
Cazenave, M., Koehl, B., Nochy, D., Tharaux, P. and Audard, V. (2014) Atteintes rénales au cours de la drépanocytose. Néphrologie & Thérapeutique , 10, 10-16. https://doi.org/10.1016/j.nephro.2013.07.366
MSD et les Manuels MSD. https://www.msdmanuals.com/fr
Saborio, P. and Scheinman, J.I. (1999) Sickle Cell Nephropathy. Journal of the American Society of Nephrology , 10, 187-192. https://doi.org/10.1681/asn.v101187
De Jong, P.E., Den Berg, L.T.W.D.J., Sewrajsingh, G.S., Schouten, H., Donker, A.J.M. and Van Eps, L.W.S. (1980) The Influence of Indomethacin on Renal Haemodynamics in Sickle Cell Anaemia. Clinical Science , 59, 245-250. https://doi.org/10.1042/cs0590245